These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13570414)

  • 1. [Opsono-phagocytic reactions in human subjects vaccinated with living attenuated vaccine against brucellosis].
    PRAVILO NP
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Feb; 29(2):107-8. PubMed ID: 13570414
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reactions following vaccination against brucellosis with living dry vaccine].
    DRANKIN DI; MALIUTIN AA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Nov; (11):21-4. PubMed ID: 13300889
    [No Abstract]   [Full Text] [Related]  

  • 3. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of immunogenesis in vaccination with living vaccine against brucellosis].
    VERSHILOVA PA
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Oct; 10():38-44. PubMed ID: 14349244
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preventive effectiveness of dry living vaccine IEM AMN SSSR against brucellosis].
    ROZOVA ZA; CHERNENKOVA NA; REZNIKOVA OIu; BOBYREVA ND; KIREEVA OK
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Nov; 11():62-6. PubMed ID: 14349271
    [No Abstract]   [Full Text] [Related]  

  • 6. [Revaccination against brucellosis with living dry epicutaneous vaccine of the Gamaleia Institute of Epidemiology and Microbiology of the Academy of Medicine of USSR].
    DRANKIN DI
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Jan; 28(1):56-60. PubMed ID: 13423777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiolotical survey of the effectiveness of brucellosis vaccine].
    ABASHIDZE TG
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Jan; 29(1):114-9. PubMed ID: 13570380
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-epidemiological characteristics of brucellosis in subjects vaccinated with living dry vaccine of the Institute of Epidemiology and Microbiology of the Academy of Medicine of USSR].
    DRANKIN DI; SIMAGINA VA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jul; (7):42-7. PubMed ID: 13257791
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problem of epidemiological effectiveness of living dry vaccine of the N.F. Gamaleia Institute of Epidemiology and Microbiology of the Academy of Medicine of USSR].
    DRANKIN DI
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Oct; 27(10):82-6. PubMed ID: 13410078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccination against brucellosis and method of selection of patients by means of a single allergic test].
    POLIAKOVA AM
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Aug; 8():63-6. PubMed ID: 13206349
    [No Abstract]   [Full Text] [Related]  

  • 11. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
    Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiologic effectiveness of prevention of brucellosis with vaccines at the N packing house].
    PAVLOVA IV; SERGEEVA EI; MARTIROSOV LA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jul; (7):40-2. PubMed ID: 13257790
    [No Abstract]   [Full Text] [Related]  

  • 13. [Result of special vaccination in prevention of brucellosis].
    CHERNENKOVA NA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Nov; (11):24-6. PubMed ID: 13300890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimentation with anti-brucellosis vaccination with various absorbable vaccines].
    GARGANI G
    Rev Pathol Gen Physiol Clin; 1956 Jan; 56(674):207-10. PubMed ID: 13323836
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological reactions in persons vaccinated against brucellosis by live dried IEM vaccine of the Academy of Medical Sciences of the USSR].
    DRANKIN DI
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Jun; 30(6):126. PubMed ID: 13676851
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological research on brucellosis and human immunization against this infection by means of attenuated living vaccine].
    ZDRODOWSKI P; VERCHILOWA P; KOTLAROVA H
    Rev Immunol Ther Antimicrob; 1956; 20(3):85-99. PubMed ID: 13351057
    [No Abstract]   [Full Text] [Related]  

  • 17. Brucellosis; the work of M. Ruiz Castaneda, M.D. and the Medical Research Institute, Mexico City, D.F.
    DE VILBISS LA
    J Am Med Womens Assoc; 1952 Nov; 7(11):412-4. PubMed ID: 12999587
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenic and protective antigens of Brucella as vaccine candidates.
    Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confronting the barriers to develop novel vaccines against brucellosis.
    Oliveira SC; Giambartolomei GH; Cassataro J
    Expert Rev Vaccines; 2011 Sep; 10(9):1291-305. PubMed ID: 21919619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.